Clinical trial
A Study to Compare Multiple Doses Intravitreal Microplasmin for Treatment of…
NCT00435539 · ThromboGenics, Industry · Completed
Key facts
| NCT number | NCT00435539 |
|---|---|
| Title | A Study to Compare Multiple Doses Intravitreal Microplasmin for Treatment of Patients With Vitreomacular Traction (MIVI-IIt) |
| Official title | A Randomized, Sham-Injection Controlled, Double-Masked, Ascending-Dose, Dose-Range-Finding Trial of Microplasmin Intravitreal Injection for Non-Surgical Posterior Vitreous Detachment (PVD) Induction for Treatment of Vitreomacular Traction (VMT). |
| Lead sponsor | ThromboGenics, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Vitreomacular Traction |
| Intervention type | Drug |
| Interventions | ocriplasmin, Sham Comparator |
| Enrollment | 60 |
| Start date | Feb 1, 2007 |
| Primary completion | Jan 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | Feb 15, 2007 |
| Last update posted | Dec 17, 2014 |
| Countries | Belgium, Germany |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: